Vivani Medical shares are trading higher after the company announced the FDA cleared the Investigational New Drug Application and lifted the clinical hold on NPM-119.
Portfolio Pulse from Benzinga Newsdesk
Vivani Medical shares are trading higher after the company announced the FDA cleared the Investigational New Drug Application and lifted the clinical hold on NPM-119.
June 13, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vivani Medical's stock is experiencing a positive impact following the FDA's clearance of the Investigational New Drug Application and the lifting of the clinical hold on NPM-119.
The FDA's clearance and lifting of the clinical hold are significant regulatory milestones that typically boost investor confidence and can lead to a rise in stock prices. This news directly impacts Vivani Medical, making it highly relevant and important for investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100